Characterization of pharmaceutical IgG and biosimilars using miniaturized platforms and LC-MS/MS
KM Wooding, W Peng… - Current pharmaceutical …, 2016 - ingentaconnect.com
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to specifically target a cell and illicit a …
patients with various diseases. MAbs are designed to specifically target a cell and illicit a …
[PDF][PDF] Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
KM Wooding, W Peng, Y Mechref - Curr Pharm Biotechnol, 2016 - researchgate.net
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
Characterization of pharmaceutical IgG and biosimilars using miniaturized platforms and LC-MS/MS
KM Wooding, W Peng, Y Mechref - Current Pharmaceutical …, 2016 - scholars.ttu.edu
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to specifically target a cell and illicit a …
patients with various diseases. MAbs are designed to specifically target a cell and illicit a …
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.
KM Wooding, W Peng, Y Mechref - Current Pharmaceutical …, 2016 - europepmc.org
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
KM Wooding, W Peng… - Current pharmaceutical …, 2016 - pubmed.ncbi.nlm.nih.gov
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to specifically target a cell and illicit a …
patients with various diseases. MAbs are designed to specifically target a cell and illicit a …
[HTML][HTML] Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
KM Wooding, W Peng, Y Mechref - Current pharmaceutical …, 2016 - ncbi.nlm.nih.gov
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.
KM Wooding, W Peng, Y Mechref - Current Pharmaceutical …, 2016 - europepmc.org
Therapeutic monoclonal antibodies (mAbs) have made a tremendous impact in treating
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
patients with various diseases. MAbs are designed to target specifically a cell and illicit a …
[引用][C] Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.
KM Wooding, W Peng, Y Mechref - Current Pharmaceutical …, 2016 - scholars.ttu.edu
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and
LC-MS/MS. — Texas Tech University Scholars Skip to main navigation Skip to search Skip to …
LC-MS/MS. — Texas Tech University Scholars Skip to main navigation Skip to search Skip to …